Role of adjuvant therapy in adenocarcinoma of the rectum

Seminars in Surgical Oncology

Volumn 17, Issue 3, 1999, Pages 189-198

  Minsky, Bruce D ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Adjuvant chemotherapy; Adjuvant radiotherapy; Anus; Biological tumor markers; Combined antineoplastic agents; Combined modality therapy; Disease free survival; Drug administration routes; Fluorouracil; High energy radiotherapy; Leucovorin; Levamisole; Mesentery surgery; Neoplasm staging; Postoperative care; Postoperative complications; Preoperative care; Radiation dosage; Rectal neoplasms; Semustine; Survival rate

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; 5 ETHYNYLURACIL; CAPECITABINE; CYCLINE; EDRECOLOMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; KI 67 ANTIGEN; LEVAMISOLE; LOMUSTINE; OXALIPLATIN; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR; TRIMETREXATE; TUMOR MARKER; UFT; VINCRISTINE;

ADENOCARCINOMA; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTINUOUS INFUSION; DIARRHEA; HUMAN; INTESTINE FUNCTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CARCINOMA; REVIEW; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; HUMANS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 0032867918     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199910/11)17:3<189::AID-SSU8>3.0.CO;2-H     Document Type: Review

References (77)

1. Minsky BD: Management of locally advanced/unresectable rectal cancer. Radiat Oncol Invest 1995;3:97-107.
2. Minsky BD, Conti JA, Huang Y, Knopf K: The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 1995;13:1409-1416.
3. Douglass HO Jr, Moertel CG, Mayer RJ, et al: Survival after postoperative combination treatment of rectal cancer [letter]. N Engl J Med 1986;315:1294-1295.
4. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715.
5. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer [Review]. JAMA 1990;264:1444-1450.
6. O'Connell MJ, Martenson JA, Weiand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-507.
7. Rockette HE, Deutsch M, Petrelli N, et al: Effect of postoperative radiation therapy (RTX) when used with adjuvant chemotherapy in Dukes' B and C rectal cancer: results from NSABP-RO2 [Abstract]. Proc Am Soc Clin Oncol 1994;13:193.
8. Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997;15:2030-2039.
9. Kollmorgen CF, Meagher AP, Wolff BG, et al: The long-term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 1994;220:676-682.
10. Paty PB, Enker WE, Cohen AM, et al: Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90-95.
11. Minsky BD, Cohen AM, Kemeny N, et al: Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218-1224.
12. Maghfoor I, Wilkes J, Kuvshinoff B, et al: Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low-lying rectal cancer [Abstract]. Proc Am Soc Clin Oncol 1997;16:274.
13. Wagman R, Minsky BD, Cohen AM, et al: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 1998;42:51-57.
14. Grann A, Minsky BD, Cohen AM, et al: Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515-522.
15. Rouanet P, Fabre JM, Dubois JB, et al: Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67-73.
16. Hyams DM, Mamounas EP, Petrelli N, et al: A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of the National Surgical Adjuvant Breast and Bowel Project Protocol R0-3. Dis Colon Rectum 1997;40:131-139.
17. Valentini V, Coco C, Cellini N, et al: Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998; 40:1067-1075.
18. Kaminsky-Forrett MC, Conroy T, Luporsi E, et al: Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935-941.
19. Ahmad NR, Nagle DA, Topham A: Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer [Abstract]. Int J Radiat Oncol Biol Phys 1997; 39:284.
20. Habr-Gama A, de Souza PM, Ribeiro U Jr, et al: Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998;41:1087-1096.
21. Rossi BM, Nakagawa WT, Novaes PE, et al: Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial. Ann Surg Oncol 1998;5:113-118.
22. Hunerbein M, Schlag PM: Three-dimensional endosonography for staging of rectal cancer. Ann Surg 1997;225:432-438.
23. Milsom JW, Czyrko C, Hull TL, et al: Preoperative biopsy of pararectal lymph nodes in rectal cancer using endoluminal ultrasonography. Dis Colon Rectum 1994;37:364-368.
24. Koehler PR, Feldberg MA, van Waes PF: Preoperative staging of rectal cancer with computerized tomography. Accuracy, efficacy, and effect on patient management. Cancer 1984;54:512-516.
25. Hadfield MB, Nicholson AA, MacDonald AW, et al: Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil. Br J Surg 1997;84:529-531.
26. deSouza NM, Hall AS, Puni R, et al: High resolution magnetic resonance imaging of the anal sphincter using a dedicated endoanal coil. Comparison of magnetic resonance imaging with surgical findings. Dis Colon Rectum 1996;39:926-934.
27. Falk PM, Gupta NC, Thorson AG, et al: Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37:153-156.
28. Herzog U, von Flue M, Tondelli P, Schuppisser JP: How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 1993;36:127-134.
29. Zlotecki RA, Mendenhall WM, Copeland EM, et al: Preoperative radiotherapy for resectable rectal cancer: improved local control is prognostic for distant metastasis occurrence and survival [Abstract]. Int J Radiat Oncol Biol Phys 1996;36:261.
30. Myerson RJ, Michalski JM, King ML, et al: Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys 1995;32:41-50.
31. Bannon JP, Marks GJ, Mohiuddin M, et al: Radical and local excisional methods of sphincter-sparing surgery after high-dose radiation for cancer of the distal 3 cm of the rectum. Ann Surg Oncol 1995;2:221-227.
32. Bosset JF, Pavy JJ, Hamers HP, et al: Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 1993;29:1406-1410.
33. Mohiuddin M, Regine WF, Marks GJ, Marks JW: High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys 1998;40:569-574.
34. Pahlman L, Glimelius B: Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187-195.
35. Frykholm GJ, Glimelius B, Pahlman L: Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-572.
36. Minsky BD: Multidisciplinary management of resectable rectal cancer [Review]. Oncology 1996;10:1701-1708, 1713-1718.
37. Chari RS, Tyler DS, Anscher MS, et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-787.
38. Stryker SJ, Kiel KD, Rademaker A, et al: Preoperative "chemoradiation" for stages II and III rectal carcinoma. Arch Surg 1996; 131:514-519.
39. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-1029.
40. Rich TA: Infusional chemoradiation for operable rectal cancer: post-, pre-, or nonoperative management? [Review] Oncology 1997;11:295-300, 305-315.
41. Minsky BD: Adjuvant therapy for rectal cancer: results and controversies. Oncology 1998;12:1129-1139.
42. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable, locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 1996;348(9042):1605-1610.
43. Glimelius B, Isacsson U, Jung B, Pahlman L: Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment [Review]. Int J Radiat Oncol Biol Phys 1997;37:281-287.
44. Cedermark B, Johansson H, Rutqvist LE, Wilking N: The Stockholm I trial of preoperative short-term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995;75:2269-2275.
45. Boulis-Wassif S, Gerard A, Loygue J, et al: Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Cancer 1984;53:1811-1818.
46. Cedermark B: The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial [Abstract]. Proc Am Soc Clin Oncol 1994;13:198.
47. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [published erratum appears in N Engl J Med 1997;336:1539]. N Engl J Med 1997;336:980-987.
48. Holm T, Singnomklao T, Rutqvist LE, Cedermark B: Adjuvant pre-operative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996;78:968-976.
49. Holm T, Rutqvist LE, Johansson H, Cedermark B: Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996; 83:964-968.
50. Frykholm GJ, Isacsson U, Nygard K, et al: Preoperative radiotherapy in rectal carcinoma - aspects of acute adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996;35:1039-1048.
51. Graf W, Dahlberg M, Osman MM, et al: Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997;43:133-137.
52. Papillon J, Gerard JP: Role of radiotherapy in anal preservation for cancers of the lower third of the rectum. Int J Radiat Oncol Biol Phys 1990;19:1219-1220.
53. Minsky BD, Cohen AM, Enker WE, Paty P: Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553-559.
54. Birnbaum EH, Dreznik Z, Myerson RJ, et al: Early effect of external beam radiation on the anal sphincter: a study using anal manometry and transrectal ultrasound. Dis Colon Rectum 1992; 35:757-761.
55. Birnbaum EH, Myerson RJ, Fry RD, et al: Chronic effects of pelvic radiation therapy on anorectal function. Dis Colon Rectum 1994;37:909-915.
56. Willett CG, Warland G, Coen J, et al: Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995;32:57-61.
57. Willett CG, Warland G, Hagan MP, et al: Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417-1424.
58. Willett CG, Hagan M, Daley W, et al: Changes in tumor proliferation of rectal cancer induced by preoperative 5-fluorouracil and irradiation. Dis Colon Rectum 1998;41:62-67.
59. Desai GR, Myerson RJ, Higashikubo R, et al: Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996;39:1090-1096.
60. Neoptolemos JP, Oates GD, Newbold KM, et al: Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer. Br J Surg 1995;82:184-187.
61. Rich TA, Sinicrope F, Stephens C, et al: Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining [Abstract]. Int J Radiat Oncol Biol Phys 1996;36:259.
62. Berger C, de Muret A, Garaud P, et al: Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-627.
63. Ahmad NR, Nagle DA: Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by local excision. Semin Radiat Oncol 1998;8:36-38.
64. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993;341(8851):457-460.
65. de Haas-Kock DF, Baeten CG, Jager JJ, et al: Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781-785.
66. Enker WE, Thaler HT, Cranor ML, Polyak T: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-346.
67. Arenas RB, Fichera A, Mhoon D, Michelassi F: Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study. Arch Surg 1998;133:608-612.
68. Aitken RJ: Mesorectal excision for rectal cancer. Br J Surg 1996;83:214-216.
69. Carlsen E, Schlichting E, Guldvog I, et al: Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-529.
70. Withers HR: Biologic basis for altered fractionation schemes. Cancer 1985;55(9 Suppl):2086-2095.
71. Coucke PA, Cuttat JF, Mirimanoff RO: Adjuvant postoperative accelerated hyperfractionated radiotherapy in rectal cancer: a feasibility study. Int J Radiat Oncol Biol Phys 1993;27:885-889.
72. Coucke PA, Sartorelli B, Cuttat JF, et al: The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:181-188.
73. Movsas B, Hanlon AL, Lanciano R, et al: Phase I dose escalating trial of hyperfractionated preoperative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:43-50.
74. Tait DM, Nahum AE, Meyer LC, et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol 1997;42:121-136.
75. Punt CJ: New drugs in the treatment of colorectal carcinoma [Review]. Cancer 1998;83:679-689.
76. Botwood N, James R, Vernon C, Price P: A phase I study of "Tomudex" (raltitrexed) with radiotherapy (RT) as adjuvant treatment in patients (pt) with operable rectal cancer [Abstract]. Proc Am Soc Clin Oncol 1998;17:277a.
77. Marsh RW, Chu NM, Vauthey JN, et al: Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996;78:217-225.